Publication | Closed Access

The stem cell factor–c-KIT pathway must be inhibited to enable apoptosis induced by BCR–ABL inhibitors in chronic myelogenous leukemia cells

Hematological MalignancyCancer ResearchMedicineApoptosisBcr–abl InhibitorsMyeloid NeoplasiaCell DeathStem Cell ResearchStem Cell TherapiesCell BiologyStem CellsRadiation OncologyCell SignalingTumor BiologyHealth Sciences